Home
KRON
KRON News

Latest Kronos Bio Inc. (KRON) News on March 31, 2025

Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023)

Simply Wall St.

11 days ago

Kronos Bio Full Year 2024 Earnings: US$1.43 loss per share (vs US$1.95 loss in FY 2023)

Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

12 days ago

Kronos Bio Reports Fourth Quarter and Full Year 2024 Financial Results

Kronos Bio Insider Ups Holding By 36% During Year

Simply Wall St.

a month ago

Kronos Bio Insider Ups Holding By 36% During Year

We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully

Simply Wall St.

3 months ago

We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully

MT Newswires

3 months ago

Kronos Bio, Genentech to Terminate Research Partnership; Shares Down Pre-Bell

Discover 3 US Penny Stocks With Market Caps Over $40M

Simply Wall St.

4 months ago

Discover 3 US Penny Stocks With Market Caps Over $40M

Kronos Bio announces interim CEO and workforce cuts of 83%

Pharmaceutical Technology

4 months ago

Kronos Bio announces interim CEO and workforce cuts of 83%

Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul

Benzinga

4 months ago

Kronos Bio Shakes Up Leadership - Cuts 83% Of Workforce Amid Strategic Overhaul

MT Newswires

4 months ago

Kronos Bio Names Deborah Knobelman Interim CEO, Cuts Workforce by 83%

Kronos Bio Announces CEO Transition and Reduction in Force

GlobeNewswire

4 months ago

Kronos Bio Announces CEO Transition and Reduction in Force

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

BioPharma Dive

4 months ago

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

Kronos Bio Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Kronos Bio Third Quarter 2024 Earnings: Beats Expectations

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024

GlobeNewswire

5 months ago

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024

Kronos mulls ‘strategic alternatives’ after axing cancer drug development

Pharmaceutical Technology

5 months ago

Kronos mulls ‘strategic alternatives’ after axing cancer drug development

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates

Zacks

5 months ago

Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

GlobeNewswire

5 months ago

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma

GlobeNewswire

5 months ago

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

GlobeNewswire

5 months ago

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors

GlobeNewswire

6 months ago

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

GlobeNewswire

6 months ago

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy

GlobeNewswire

6 months ago

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy

Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer

GlobeNewswire

6 months ago

Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer

After Plunging -5.53% in 4 Weeks, Here's Why the Trend Might Reverse for Kronos Bio (KRON)

Zacks

7 months ago

After Plunging -5.53% in 4 Weeks, Here's Why the Trend Might Reverse for Kronos Bio (KRON)

Kronos Bio Announces Participation in Medical and Investor Conferences in September

GlobeNewswire

7 months ago

Kronos Bio Announces Participation in Medical and Investor Conferences in September

After Plunging -23.49% in 4 Weeks, Here's Why the Trend Might Reverse for Kronos Bio (KRON)

Zacks

7 months ago

After Plunging -23.49% in 4 Weeks, Here's Why the Trend Might Reverse for Kronos Bio (KRON)

Kronos Bio Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

8 months ago

Kronos Bio Second Quarter 2024 Earnings: Beats Expectations

Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update

GlobeNewswire

8 months ago

Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

8 months ago

CureVac N.V. (CVAC) Expected to Beat Earnings Estimates: Should You Buy?

Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

8 months ago

Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy?

MT Newswires

8 months ago

Kronos Bio Says 1st Patient Dosed With KB-0742 in Expansion Group Focused on Platinum-Resistant Ovarian Cancer

Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer

GlobeNewswire

8 months ago

Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer

Shareholders May Be More Conservative With Kronos Bio, Inc.'s (NASDAQ:KRON) CEO Compensation For Now

Simply Wall St.

9 months ago

Shareholders May Be More Conservative With Kronos Bio, Inc.'s (NASDAQ:KRON) CEO Compensation For Now

Insider Spends US$3.1m Buying More Shares In Kronos Bio

Simply Wall St.

9 months ago

Insider Spends US$3.1m Buying More Shares In Kronos Bio

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

10 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

10 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

10 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

10 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

10 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

10 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed

PR Newswire

10 months ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

10 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Here's Why We're Watching Kronos Bio's (NASDAQ:KRON) Cash Burn Situation

Simply Wall St.

10 months ago

Here's Why We're Watching Kronos Bio's (NASDAQ:KRON) Cash Burn Situation

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

10 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

10 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

10 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

10 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

10 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

10 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

10 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

10 months ago

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events

GlobeNewswire

10 months ago

Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events

Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer

GlobeNewswire

10 months ago

Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer

Down -5.63% in 4 Weeks, Here's Why Kronos Bio (KRON) Looks Ripe for a Turnaround

Zacks

10 months ago

Down -5.63% in 4 Weeks, Here's Why Kronos Bio (KRON) Looks Ripe for a Turnaround

Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates

Zacks

a year ago

Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates

Kronos Bio Reports First-Quarter 2024 Financial Results

GlobeNewswire

a year ago

Kronos Bio Reports First-Quarter 2024 Financial Results

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Zacks

a year ago

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

a year ago

Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Kronos Bio (KRON) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a year ago

Kronos Bio (KRON) Upgraded to Buy: What Does It Mean for the Stock?

Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results

GlobeNewswire

a year ago

Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results

Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway

GlobeNewswire

a year ago

Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway

Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting

GlobeNewswire

a year ago

Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

GlobeNewswire

a year ago

Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference

Research Solutions to Announce Second Quarter Fiscal 2024 Results on Thursday, February 8, 2024

PR Newswire

a year ago

Research Solutions to Announce Second Quarter Fiscal 2024 Results on Thursday, February 8, 2024

Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer

GlobeNewswire

a year ago

Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer

Why First Savings Financial (FSFG) is a Great Dividend Stock Right Now

Zacks

a year ago

Why First Savings Financial (FSFG) is a Great Dividend Stock Right Now

Associated Press Finance

a year ago

Dime Community: Q4 Earnings Snapshot

Dime Community Bancshares, Inc. Reports Fourth Quarter 2023 Results

GlobeNewswire

a year ago

Dime Community Bancshares, Inc. Reports Fourth Quarter 2023 Results

Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement

GlobeNewswire

a year ago

Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement

Manitex International Appoints Shinichi Iimura to Board of Directors

Business Wire

a year ago

Manitex International Appoints Shinichi Iimura to Board of Directors

Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch

CNW Group

a year ago

Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch

Q3 Earnings Outperformers: Torrid (NYSE:CURV) And The Rest Of The Apparel Retailer Stocks

StockStory

a year ago

Q3 Earnings Outperformers: Torrid (NYSE:CURV) And The Rest Of The Apparel Retailer Stocks

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

StockStory

a year ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

abrdn Income Credit Strategies Fund (ACP) Announces Results of the Special Shareholder Meeting Relating to Proposed Reorganization with Two First Trust-Advised Closed-End Funds

ACCESSWIRE

a year ago

abrdn Income Credit Strategies Fund (ACP) Announces Results of the Special Shareholder Meeting Relating to Proposed Reorganization with Two First Trust-Advised Closed-End Funds

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

GlobeNewswire

a year ago

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease

Register for Capital Link’s 2024 Virtual Corporate Presentation Series

GlobeNewswire

a year ago

Register for Capital Link’s 2024 Virtual Corporate Presentation Series

Snap-on (SNA) Looks Well Placed on RCI Initiative & Cost Plans

Zacks

a year ago

Snap-on (SNA) Looks Well Placed on RCI Initiative & Cost Plans

Affimed Announces Leadership Change and Organizational Restructuring

GlobeNewswire

a year ago

Affimed Announces Leadership Change and Organizational Restructuring

Volition Issues Business Review 2023

PR Newswire

a year ago

Volition Issues Business Review 2023

LivePerson recognized in Conversation Automation Solutions For B2B Landscape Report

PR Newswire

a year ago

LivePerson recognized in Conversation Automation Solutions For B2B Landscape Report

We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate

Simply Wall St.

a year ago

We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate

Is ProQR (PRQR) Stock a Solid Choice Right Now?

Zacks

a year ago

Is ProQR (PRQR) Stock a Solid Choice Right Now?

FinWise Bancorp (FINW) is on the Move, Here's Why the Trend Could be Sustainable

Zacks

a year ago

FinWise Bancorp (FINW) is on the Move, Here's Why the Trend Could be Sustainable

MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads

GlobeNewswire

a year ago

MediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial Loads

Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate

GlobeNewswire

a year ago

Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate

Canada’s First Bidirectional EV Charging Hub Launches in British Columbia

GlobeNewswire

a year ago

Canada’s First Bidirectional EV Charging Hub Launches in British Columbia

Insider Sell Alert: Director Mike Brooks Sells 4,000 Shares of Rocky Brands Inc (RCKY)

GuruFocus.com

a year ago

Insider Sell Alert: Director Mike Brooks Sells 4,000 Shares of Rocky Brands Inc (RCKY)

Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

PR Newswire

a year ago

Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

With 45% ownership, Spok Holdings, Inc. (NASDAQ:SPOK) has piqued the interest of institutional investors

Simply Wall St.

a year ago

With 45% ownership, Spok Holdings, Inc. (NASDAQ:SPOK) has piqued the interest of institutional investors

7 Stock Winners That Are Up 1,000% or More in 2023

InvestorPlace

a year ago

7 Stock Winners That Are Up 1,000% or More in 2023

The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors

GlobeNewswire

a year ago

The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors

Immutep Receives A$2.6 million R&D Tax Incentive from French Government

GlobeNewswire

a year ago

Immutep Receives A$2.6 million R&D Tax Incentive from French Government

Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

GlobeNewswire

a year ago

Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript

enGene Appoints Ryan Daws as Chief Financial Officer

CNW Group

a year ago

enGene Appoints Ryan Daws as Chief Financial Officer

Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire

a year ago

Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings

Simply Wall St.

a year ago

Jean-Luc Butel Buys Handful Of Shares In Rani Therapeutics Holdings

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire

a year ago

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

GlobeNewswire

a year ago

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

Kronos Bio Up 47%, Insider Buyers Are Up 31%

Simply Wall St.

a year ago

Kronos Bio Up 47%, Insider Buyers Are Up 31%

Share on Social Networks: